Research output per year
Research output per year
Research output
- 7 Article
Search results
-
2021
Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells
van Schalkwyk, M. C. I., van der Stegen, S. J. C., Bosshard-Carter, L., Graves, H., Papa, S., Parente-Pereira, A. C., Farzaneh, F., Fisher, C. D., Hope, A., Adami, A. & Maher, J., 15 Jul 2021, In: Cells. 10, 7, 1797.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
2017
CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
Thayaparan, T., Petrovic, R. M. G., Achkova, D. Y., Zabinski, T. S., Davies, D. M., Klampatsa, A., Parente Pereira, A. C., Whilding, L. M., Van Der Stegen, S. J. C., Woodman, N., Sheaf, M., Cochran, J., Spicer, J. F. & Maher, J., 1 Oct 2017, In: OncoImmunology. 6, 12, e1363137.Research output: Contribution to journal › Article › peer-review
Open AccessFile45 Citations (Scopus)204 Downloads (Pure) -
2014
Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid
Parente-Pereira, A. C., Shmeeda, H., Whilding, L. M., Zambirinis, C. P., Foster, J., Van Der Stegen, S. J. C., Beatson, R., Zabinski, T., Brewig, N., Sosabowski, J. K., Mather, S., Ghaem-Maghami, S., Gabizon, A. & Maher, J., 1 Dec 2014, In: Journal of Immunology. 193, 11, p. 5557-5566 10 p.Research output: Contribution to journal › Article › peer-review
40 Citations (Scopus) -
2013
Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?
Van Der Stegen, S., Davies, D. M., Wilkie, S., Foster, J., Sosabowski, J., Burnet, J., Whilding, L., Petrovic, R., Ghaem-Maghami, S., Mather, S., Jeannon, J-P., Parente Pereira, A. & Maher, J., 1 Nov 2013, In: Journal of Immunology. 191, 9, p. 4589-4598 10 p.Research output: Contribution to journal › Article › peer-review
102 Citations (Scopus) -
Synergistic chemo-immunotherapy of epithelial ovarian cancer using ErbB re-targeted T-cells combined with carboplatin.
Parente Pereira, A., Whilding, L., Brewig, N., Van Der Stegen, S., Davies, D. M., Wilkie, S., van Schalkwyk, M., Maher, J. & Ghaem-Maghami, S., Sept 2013, In: Journal of Immunology. 191, 5, p. 2437-2445 8 p., N/A.Research output: Contribution to journal › Article › peer-review
42 Citations (Scopus) -
2012
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
Wilkie, S., van Schalkwyk, M. C. I., Hobbs, S., Davies, D. M., van der Stegen, S. J. C., Pereira, A. C. P., Burbridge, S. E., Box, C., Eccles, S. A. & Maher, J., Oct 2012, In: Journal of Clinical Immunology. 32, 5, p. 1059-1070 12 p.Research output: Contribution to journal › Article › peer-review
372 Citations (Scopus) -
Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells
Davies, D. M., Foster, J., Van Der Stegen, S. J. C., Parente-Pereira, A. C., Chiapero-Stanke, L., Delinassios, G. J., Burbridge, S. E., Kao, V., Liu, Z., Bosshard-Carter, L., Van Schalkwyk, M. C. I., Box, C., Eccles, S. A., Mather, S. J., Wilkie, S. & Maher, J., Apr 2012, In: Molecular Medicine. 18, 1, p. 565-576 12 p.Research output: Contribution to journal › Article › peer-review
87 Citations (Scopus)